Table of Contents Author Guidelines Submit a Manuscript
Neural Plasticity
Volume 2016, Article ID 1207393, 12 pages
http://dx.doi.org/10.1155/2016/1207393
Review Article

P2Y Receptors in Synaptic Transmission and Plasticity: Therapeutic Potential in Cognitive Dysfunction

1Institute of Science and Technology Austria (IST Austria), Am Campus 1, 3400 Klosterneuburg, Austria
2Institute of Neurophysiology, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany

Received 30 November 2015; Accepted 10 February 2016

Academic Editor: Francisco Ciruela

Copyright © 2016 Segundo J. Guzman and Zoltan Gerevich. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

ATP released from neurons and astrocytes during neuronal activity or under pathophysiological circumstances is able to influence information flow in neuronal circuits by activation of ionotropic P2X and metabotropic P2Y receptors and subsequent modulation of cellular excitability, synaptic strength, and plasticity. In the present paper we review cellular and network effects of P2Y receptors in the brain. We show that P2Y receptors inhibit the release of neurotransmitters, modulate voltage- and ligand-gated ion channels, and differentially influence the induction of synaptic plasticity in the prefrontal cortex, hippocampus, and cerebellum. The findings discussed here may explain how P2Y1 receptor activation during brain injury, hypoxia, inflammation, schizophrenia, or Alzheimer’s disease leads to an impairment of cognitive processes. Hence, it is suggested that the blockade of P2Y1 receptors may have therapeutic potential against cognitive disturbances in these states.

1. Introduction

Adenosine triphosphate (ATP), the general currency in energy conversions within all living cells, was discovered in 1929 in muscle tissue [1, 2]. In the same year, Drury and Szent-Györgyi described that ATP and its metabolite, adenosine, exhibit potent extracellular activity on the heart and coronary blood vessels [3]. Follow-up studies revealed that extracellular purines are involved in several central and peripheral physiological mechanisms [4] and in the early 1970s Burnstock suggested the existence of purinergic neurotransmission with the release of ATP and its actions on purinergic receptors [5, 6]. In the 1980s it was suggested that ATP receptors, the so called P2 receptors, can be pharmacologically separated into two subtypes: the P2X and the P2Y receptors [7]. While P2X receptors are ligand-gated ion channels permeable for Na+, K+, and Ca2+ [8, 9], P2Y receptors are coupled to G proteins and activate different intracellular cascades [1012].

Eight different P2Y receptors (P2Y1, P2Y2, P2Y4, P2Y6, P2Y11, P2Y12, P2Y13, and P2Y14) have been identified exhibiting a different sensitivity to ATP (P2Y11), ADP (P2Y1, P2Y12, and P2Y13), UTP/ATP (P2Y2 and P2Y4), UDP (P2Y6), or UDP-glucose (P2Y14) [13]. P2Y1, P2Y2, P2Y4, P2Y6, and P2Y11 receptors are coupled to Gq proteins, the activation of which stimulates phospholipase C and subsequent release of Ca2+ from intracellular stores and activation of protein kinase C in response to inositol 1,4,5-trisphosphate and diacylglycerol production, respectively [13, 14]. The P2Y11 receptor can also couple to Gs stimulating adenylate cyclase and increasing generation of cAMP [15]. P2Y12–14 receptors couple to Gi, effectively inhibiting adenylate cyclase and decreasing cAMP production [13].

P2Y receptors are expressed ubiquitously in the body, including the central nervous system (CNS) [16]. In the CNS, they are localized on neurons, astrocytes, oligodendrocytes, and microglia with physiological roles in neurotransmission, neurogenesis, and glial cell communication [5, 1720] while they are also involved in a number of peripheral pathophysiological processes, including inflammation, ischemia, and pain [2127].

ATP can be released from different cell types of the brain such as neurons [28, 29], astrocytes [30], and microglia [31, 32] through exocytotic release mechanism [33], connexin/pannexin hemichannels [34], or P2X7 receptors [35]. After release of ATP, it takes approximately 200 ms before it is hydrolyzed to adenosine in the extracellular space by ectonucleotidases [36, 37]. Although it has been suggested that ATP is involved in fast synaptic transmission in the brain via postsynaptic P2X receptors [3841], this form of depolarization seems to be insufficient to trigger action potentials in the postsynaptic cells suggesting that the main effect of ATP is neuromodulation similar to other classical neuromodulators such as monoamines and acetylcholine [42]. In these neuromodulational effects of ATP P2Y receptors play an important role. In this review we shall overview the main effects of P2Y receptors on synaptic transmission and plasticity with special emphasis on their network effects and therapeutic potentials in cognitive dysfunction.

2. Modulation of Synaptic Transmission

2.1. Modulation of Neurotransmitter Release

P2Y receptors have been shown to inhibit the release of a number of neurotransmitters in the CNS [43] (Figures 1 and 2). In the prefrontal cortex, P2Y1 receptors have been colocalized with synaptophysin and vGLUT3 suggesting that this receptor subtype is expressed in presynaptic terminals releasing glutamate [44]. P2Y1, P2Y2, P2Y4, P2Y12, and P2Y13 receptors were shown to inhibit glutamate release from the sensory terminals in the spinal cord [45, 46], from Schaffer collateral synapses of the hippocampus [4749] and in the cerebral cortex [50]. Underlying this inhibitory effect is most likely a membrane delimited inhibition of N-type voltage-activated calcium channels (VACCs) in the presynaptic terminals via the Gβγ subunit (see below) [45, 51]. GABA release from basket onto Purkinje cells in the cerebellum was also found to be inhibited by the activation of P2Y4 receptors [52]. Noradrenaline release was blocked by P2Y1, P2Y12, and P2Y13 receptors in the spinal cord [46], in the hippocampus [53, 54], and in the cortex [55], possibly via inhibition of VACCs [56]. Similarly, serotonin release in the cortex was decreased after P2Y receptor activation [57]. The modulation of dopamine release by P2Y1 receptors seems to be more complex [5860]; dopaminergic terminals in the prefrontal cortex (PFC) do not contain P2Y1 receptors suggesting that multisynaptic mechanisms are involved [44]. In summary, presynaptically located P2Y receptors affect the release machinery of glutamate, GABA, and other neuromodulators. Although the most likely mechanism is the reduction of the release probability due to reduction of presynaptic calcium influx, alternative explanations, such alteration of the fusion machinery or other effects on the pool of vesicles, cannot be entirely discarded.

Figure 1: Modulation of excitatory synaptic transmission by P2Y receptors in the CNS. The model synapse shows the main presynaptic and postsynaptic effects of P2Y receptors described in different areas of the brain. For more details see text. AMPAR, AMPA receptor; GIRK, G protein-coupled inwardly rectifying potassium channel; Glu, glutamate; KCa, calcium-activated potassium channel; LTD, long-term depression; NMDAR, NMDA receptor, P2YR, P2Y receptor; P2Y1R, P2Y1 receptor; TRP, transient receptor potential channel; VACC, voltage-activated calcium channel.
Figure 2: Modulation of inhibitory synaptic transmission by P2Y receptors in the CNS. The cartoon shows an idealized inhibitory (GABAergic) synapse between an inhibitory interneuron and an excitatory principal cell. The effects of P2Y receptors have been described in different brain areas. For more details see text. GABAAR, GABAA receptor; Glu, glutamate; LTP, long-term potentiation; P2YR, P2Y receptor; P2Y1R, P2Y1 receptor.
2.2. Modulation of Neurotransmitter Receptors

Activation of P2Y receptors has been shown to modulate numerous membrane receptors and channels in the CNS [61] (Figures 1 and 2). Relatively few data exist demonstrating that P2Y receptors modulate other G protein-coupled receptors. The internalization of the metabotropic glutamate receptor 1 (mGluR1), normally triggered by glutamate, can also be triggered by activation of P2Y1 receptors [62].

In addition, various interactions of P2Y receptors with ionotropic receptors are known. Postsynaptically located NMDA receptors were inhibited by P2Y1 receptor activation in layer 5 pyramidal cells of the PFC by the Gβγ subunit [63, 64] (Figure 1). On the contrary, P2Y4 receptors exerted positive influence on NMDA receptors. However, this effect required the release of glutamate from astrocytes via P2Y4 receptors, which acts on postsynaptic group I mGluRs to enhance the NMDA-mediated current [65]. The sensitivity of postsynaptic GABAA receptors in Purkinje cells was enhanced by P2Y1 receptor activation through a Gq-mediated increase in intracellular calcium concentration [66] (Figure 2). P2Y2 receptors enhanced currents through Ca2+ permeable transient receptor potential vanilloid 1 (TRPV1) channels [6769]. Although the interaction was found in the peripheral nervous system, TRPV1 are also expressed in the cerebral cortex and hippocampal pyramidal cells [70] and exert a role in synaptic plasticity [71]. P2X receptors have a Ca2+ permeability comparable to NMDA receptors [42, 72] that make them potential candidates for the induction of synaptic plasticity. P2X receptors were inhibited by the activation of P2Y1 receptors [23, 24].

In summary, P2Y receptors differentially influence the postsynaptic effects of neurotransmitters. Excitatory transmission mediated by postsynaptic NMDA receptors is inhibited by the activation of P2Y receptors, whereas inhibitory transmission through GABAA receptors seems to be enhanced.

2.3. Modulation of Voltage-Gated Ion Channels

A typical downstream effect of G protein-coupled receptors is to regulate activity of voltage-gated ion channels. P2Y receptors modulated a number of channels expressed in the CNS and that are critically involved in both synaptic transmission and plasticity [61, 73] (Figure 1). VACCs are a common target of P2Y receptors [74]. Almost all P2Y receptor subtypes have been shown to inhibit N-type VACCs [45, 51, 7479] by the βγ subunit of the G protein binding to the channel in a membrane delimited manner [45, 51]. In addition, P/Q-type VACCs were inhibited by the activation of Gβγ [74, 80], whereas the inhibition of the L-type channels seems to involve diffusible second messengers and protein kinases activated by Gα [8183]. N- and P/Q-type channels are involved in fast presynaptic neurotransmitter release in the CNS; L-type channels are rather localized postsynaptically and regulate dendritic signal integration, neuronal excitability, synaptic plasticity, and gene expression [84]. Thus, P2Y receptors are able to affect all these neuronal processes by interacting with different VACC subtypes (Figure 1).

Different types of potassium channels were shown to be modulated by P2Y receptors [73] (Figure 1). Voltage-gated KCNQ2/3 channels are located in the perisomatic region of pyramidal cell dendrites and are typically closed by activation of Gq-coupled receptors [85]. Almost all subtypes of P2Y receptors have been shown to inhibit KCNQ2/3 channels by activating Gq and intracellular Ca2+-dependent mechanisms or by PIP2 depletion [8689]. KCNQ2/3 channels open as neurons approach the threshold for action potential. Because their activation is slow, they are not involved in the repolarization but rather in the afterhyperpolarization thus preventing burst firing of the cell [90]. Their inactivation by a G protein-coupled receptor such as P2Y facilitates membrane excitability and may have a role in the modulation of dendritic integration.

G protein-coupled inwardly rectifying potassium (GIRK1,2,4) channels also contribute to the hyperpolarization of neurons [91] and were found to be activated by P2Y1, P2Y2, and P2Y12 receptors [9296]. Interestingly, the fast activation of the GIRK channels by Gβγ and the subsequent hyperpolarization of the membrane were followed in case of P2Y1 and P2Y2 receptors by a slower inhibition of the channel by Gα and the subsequent activation of soluble second messengers within the following minutes [92, 95, 96]. While P2Y4 and P2Y6 receptors only inhibited GIRK channels, P2Y12 receptors only opened them [96]. The slower inhibition is also able to reduce the activation of the channel by other GPCRs, for example, by norepinephrine. The fast activation of the potassium channel causes a stabilization of the resting membrane potential around the potassium equilibrium potential, whereas the slow inactivation is able to depolarize neurons expressing this pathway. In addition, neuronal calcium-activated potassium channels were shown to be activated by P2Y1 receptors. The increase in intracellular Ca2+ upon activation of Gq-coupled P2Y receptors opens these potassium channels and hyperpolarizes the membrane [97100].

In conclusion, depending on the subcellular expression, P2Y receptors acting on voltage-gated membrane channels are able to inhibit neurotransmitter release, modulate dendritic integration, facilitate neuronal excitability, or affect other various neuronal functions such as synaptic plasticity or gene expression.

3. Modulation of Neuronal Circuits

A number of studies investigated the cellular and subcellular distribution of P2Y receptors in the brain. In the hippocampus, P2Y1 receptors were located on somata and apical and basal dendrites of pyramidal cells [54, 101, 102]. Additionally, interneurons close to the pyramidal cell layer [101103] or stratum radiatum interneurons expressing calbindin or calretinin were also stained for P2Y1 receptors [104]. While activation of P2Y1 receptors did not change the membrane potential in pyramidal cells, their activation on interneurons induced an inward nonselective cationic current likely via activating TRP channels and suppressing the K+ conductance (Figure 2) [103, 104]. This depolarized the interneuron membrane by ~10 mV and increased the firing frequency of the cells resulting in increased IPSC frequency in pyramidal neurons [103, 104]. In the cerebral cortex, P2Y1 receptors were located on somata and dendrites of pyramidal cells [44, 101], on axon terminals [44], and on parvalbumin containing GABAergic cells in the PFC [44]. They were also described on stellate-like cells in the sensory-motor cortex, medial temporal cortex, and PFC [101]. P2Y receptors seem to have similar roles in the cerebellar cortex, where, together with P2X receptors, they were found to increase the activity of inhibitory basket and stellate neurons projecting onto Purkinje cells and thus decreased the main cerebellar output activity [66, 105, 106]. Therefore, it can be concluded that although purinergic P2Y receptors display an excitatory effect on cell somata on the cellular level, they increase the overall inhibition in two different circuits in the brain by selectively stimulating inhibitory GABAergic interneurons [42].

Although tonic inhibition by volume release of GABA represents one form of cortical inhibition [107], the diversity of GABAergic interneurons in the cortex suggests that their role in neuronal circuits cannot be entirely assigned to a general inhibition. Rather, the role of interneuron firing has to be understood in context of the circuit to which the interneuron type contributes. Interneurons gate the information flow within a circuit and are thus important to coordinate networks [108]. Different interneuron subtypes have been described, involved in different network functions such as dendrite-targeting interneurons (modulation of synaptic efficacy and plasticity of excitatory inputs onto pyramidal cells), interneuron specific interneurons (inhibition of other interneurons), and perisomatic interneurons (synchronization of firing and generation of network oscillations) [109111]. To understand how P2Y receptors affect neuronal networks, the effects of P2Y receptors on identified interneuron types need to be addressed. Therefore, more information is needed in relation to which interneurons express functional purinergic receptors and how this affects the activity of the network.

The effect of P2Y receptors on neuronal networks was investigated in the hippocampus [112], where P2Y1 receptors displayed a stimulatory effect on gamma oscillations in the CA3 area. This was likely mediated by the depolarization of parvalbumin containing perisomatic inhibitory basket cells [103] known to be responsible for the synchronization in the gamma band by rhythmic release of GABA onto pyramidal cells [113]. However, the inhibitory effect of P2X receptors on oscillations seems to be the dominating effect of endogenously released ATP [112]. On the other hand, P2Y receptors play no role in epileptic network activity [114]. Gamma oscillations are involved in higher cognitive functions in the brain by functionally connecting neurons within a local network and between assemblies in different brain areas [115]. In addition, disturbed gamma oscillations have been observed in a line of neuropsychiatric diseases such as schizophrenia, autism spectrum disorders, and Alzheimer’s disease (AD) [116, 117]. We suggest that P2Y1 receptors, expressed on perisomatic interneurons, are in an ideal position to effectively modulate gamma oscillations and by this mechanism cognitive functions and the development of psychiatric diseases.

In conclusion, P2Y receptors are expressed postsynaptically on dendrites of pyramidal cells and possibly on glutamatergic terminals. In addition, they are present on different types of interneurons in the cortex, including the parvalbumin containing basket cells. It seems likely that, on a network level, P2Y receptors selectively excite interneurons in different cortical areas such as the hippocampus and the cerebellum. Due to the diversity of cortical and hippocampal interneuron subtypes and their physiological functions within the circuit it is of great interest to better understand the cellular distribution of purinergic receptors on different interneuron types.

Gap junctions contribute to network synchronization and are an essential part in the generation and modulation of network activity [118]. Pannexin/connexin hemichannels, on the other hand, are also involved in the release of ATP [119]. Pannexin 1 channels have been shown to be activated by P2Y receptors [120] suggesting that P2Y receptors are able to increase the fast electric communication between cells.

4. Involvement in Gliotransmission

The term tripartite synapse describes that, besides the presynaptic nerve terminal and the postsynaptic part of the neuron, processes of astrocytes also participate in the synaptic signaling by bidirectional regulation of neuronal communication [121123]. Microglia also contact synapses and oligodendroglia have additionally been found to express receptors for neurotransmitters [124, 125]. Astrocytes detect synaptic activity via ionotropic or metabotropic neurotransmitter receptors [126] which cause changes of astrocytic intracellular Ca2+ inducing the release of various signaling molecules, such as glutamate, ATP, and D-serine [30]. Gliotransmitters have been shown to act on neurons in a timescale of seconds to minutes to regulate synaptic transmission and plasticity. ATP has a twofold role in the bidirectional neuron-glia communication. First, ATP released from neurons upon activity or during pathological conditions stimulates astrocytes by activation of P2Y1 receptors [123] (Figures 1 and 2). Second, ATP released from astrocytes can influence the function of neurons via activation of P2X and P2Y neuronal receptors [127] (Figures 1 and 2). Moreover, P2Y1 receptors on neighboring astrocytes are able to amplify the astrocyte stimulation by mediating the propagation of Ca2+ waves within the astrocytic network [128]. Bidirectional signaling between glia and neurons occurs by volume transmission [129, 130], and the concentration of the released transmitter drops rapidly from the release site. For that reason, receptors that are involved in neuron-glia-neuron communication, such as purinergic receptors, must have a high affinity for its agonist and a slow desensitization [122].

5. P2Y Receptors and Synaptic Plasticity

Several lines of evidence indicate that large amounts of ATP released under pathological conditions such as brain injury or ischemia are able to trigger synaptic plasticity by activation of P2X receptors [131136]. This plasticity was found to be bidirectional depending on the amount and dynamics of Ca2+ influx through P2X channels [131, 132, 137]. Interestingly, ATP released under more physiological conditions is also able to modulate synaptic plasticity acting on P2X receptors. This modulation was shown to be an inhibition of long-term potentiation (LTP) via Ca2+-dependent inactivation of NMDA receptors [138, 139] or a facilitation of LTP in the hippocampus [134, 140]. It has been suggested that a moderate and slow increase of intracellular Ca2+ generally induces a depression of synaptic transmission via the activation of protein phosphatases and the subsequent internalization of AMPA receptors in the membrane, whereas stronger and faster Ca2+ changes induce LTP by activation of protein kinases [136].

Aside from P2X channels, P2Y receptors were also found to have a modulatory role in synaptic plasticity. In the medial habenula nucleus, a region involved in stress, depression, and nicotine withdrawal [141], LTP of AMPA-receptor mediated currents was observed after a 5-minute application of UTP or UDP [142] via activation of presynaptic P2Y4 receptors.

In the cerebellum, P2X receptors have been described on Purkinje cells [143, 144], but ATP was not able to evoke membrane conductances suggesting the absence of functional P2X receptors [105, 106]. On the contrary, P2Y receptor activation was shown to evoke Ca2+ transients [66, 145]. Accordingly, activation of P2Y receptors induced LTP of the GABAergic transmission between cerebellar interneurons and Purkinje cells via Ca2+-dependent increase of GABAA receptor sensitivity [66] (Figure 2).

In the CA1 area of the hippocampus, ATP released from astrocytes upon stimulation resulted in heterosynaptic long-term depression (LTD) of synapses from untetanized neighboring neurons. This was caused by the activation of presynaptic P2Y receptors and the inhibition of glutamate release [149]. Heterosynaptic LTD increases the spatial sharpness of activity-dependent induced LTP. The findings indicate that ATP release from activated astrocytes and the subsequent activation of P2Y receptors are involved in this form of plasticity.

In layer 5 pyramidal cells of the PFC, activation of P2Y1 receptors decreased the proportion of cells that develop LTD [64] whereas blockade of P2Y1 receptors increased the fraction of plastic cells. In the same cells, pairing a low-frequency presynaptic stimulation with a postsynaptic depolarization induced LTD of excitatory postsynaptic currents [150] (Figure 1). The induction of LTD was dependent on the intracellular increase of calcium via mGluR1s and VACCs. Activation of P2Y1 receptors inhibited the induction of LTD. This blockade was absent in the presence of selective antagonists and in mice lacking P2Y1 but not P2Y2 receptors confirming the sole involvement of P2Y1 receptors. P2Y receptors inhibited Ca2+ transients in apical dendrites of pyramidal cells suggesting that this is the mechanism responsible for the inhibition of LTD by P2Y1 receptors. In addition, ATP, released under hypoxia, was found to inhibit LTD. This effect was mediated by P2Y1 receptors because application of a P2Y1 receptor antagonist during hypoxia allowed the induction of LTD [150].

These data suggest that effects of P2Y receptors on synaptic plasticity in the hippocampus and cerebellar cortex are different than those found in the PFC. While the effect of P2Y receptors in the hippocampus and cerebellar cortex was to develop both LTP and heterosynaptic LTD, the activation of P2Y1 receptors caused an inhibition of LTD in the PFC.

6. Pathophysiological Role of Central P2Y Receptors

Among P2Y receptors, P2Y1 receptors were suggested as one of the predominant targets of ATP in mediating danger signals in the brain during, for example, ischemia [22, 146, 151] or trauma [148, 152]. One of the main roles of P2Y1 receptors under pathological circumstances is the modulation of astrocytic networks by mediation of Ca2+ waves and activation of astrocytes upon mechanical injury [153], ischemia [154], or AD [155]. The Ca2+ waves evoked by mechanical trauma depressed the activity of neural circuits after mechanical injury [148]. Blockade or deletion of the P2Y1 receptors was shown to reduce the infarct volume [22] and cell death in the hippocampus [148] suggesting the mediatory role of the receptor in these processes. P2Y1 receptors were found to colocalize with neurofibrillary tangles and amyloid β (Aβ) plaques characteristic to AD [156] and reactive astrocytes near Aβ plaques showed enhanced P2Y1 receptor mediated Ca2+ signaling [155]. The astrocytic hyperactivity could be blocked by inhibiting the release of ATP or by pharmacological antagonism of P2Y1 receptors. This suggests that substances that prevent the effect of ATP on P2Y1 receptors could be used as therapeutic tools for the treatment of AD [157, 158].

On the contrary, activation of other P2Y receptors was described to have neuroprotective effects in neuroinflammatory processes such as AD [158]. While activation of the P2Y2 receptors stimulated neurite outgrow and nonamyloidogenic processing of amyloid precursor protein [159] as well as uptake of Aβ [160], knockdown of the receptors was shown to increase AD pathology [161]. Similarly, P2Y4 receptors present on microglia were also found to play a role in the uptake of Aβ [162] and P2Y12 receptors were described to stimulate microglial migration towards neuronal damage [163]. Finally, activation of P2Y13 receptors on rat primary cerebellar neurons was shown to protect against oxidative stress-induced neuronal death [164].

Emerging evidence indicates that P2Y1 receptors are involved in the development of cognitive deficits after traumatic brain injury or focal cerebral stroke (Table 1). Antagonism of P2Y1 receptors improved cognitive deficits after controlled cortical impact brain injury [148]. Short (45 min) middle cerebral artery occlusion (MCAO) caused long-lasting sensory-motor and cognitive deficits in mice and rats [147]. While the neurological deficits recovered within weeks, cognitive deficits persisted for long time representing the main clinical problem after ischemia. In P2Y1 knockout mice and after antagonism of P2Y1 receptors, the cognitive decline after MCAO completely failed, whereas the transient sensory-motor symptoms were still present [147]. Similarly, permanent MCAO induced neuronal damage, astrogliosis, and microgliosis and decreased working and reference memory performances [146]. P2Y1 receptor antagonism attenuated the neuronal damage and the cognitive performance without inhibiting the astrocytic or microglial reactivity upon brain injury [146] suggesting that neuronal mechanisms are predominantly involved in the neuroprotective effects of P2Y1 receptor antagonism. Application of a selective P2Y1 receptor agonist into the medial PFC impaired cognitive performances in working memory and learning tasks [44]. In the same study, stimulation of P2Y1 receptors was found to attenuate prepulse inhibition of the acoustic startle reflex without affecting the startle response amplitude [44]. Deficits of prepulse inhibition indicate the reduced capability to filter out unnecessary information that is observed in schizophrenic patients [147].

Table 1: Pharmacological or genetic P2Y1 receptor intervention and cognition in animals.

All together, we suggest that the procognitive and neuroprotective effects provided by P2Y1 receptor antagonists may have two components. First, the reduction of glial cell activation may inhibit the network depressing effect of astrocytic calcium waves. Second, the modulation of neuronal communication might influence synaptic transmission, plasticity, and network activity such as neuronal oscillations. The presented data indicate that P2Y receptors, particularly P2Y1 receptors, are emerging targets for the treatment of pathological processes that involve cognitive dysfunction. Antagonists of the P2Y1 receptor may protect against cognitive impairments after brain injury and have nootropic effects. In contrast, activation of P2Y2, P2Y4, P2Y12, and P2Y13 receptors may have a protective effect and might be beneficial in the treatment of neurodegenerative diseases.

7. Conclusion

P2Y receptors are activated by ATP released from astrocytes and neurons upon increased neuronal activity or under pathophysiological conditions. They are able to modulate synaptic transmission and plasticity by interactions with voltage-activated calcium and potassium channels, as well as ionotropic receptors. In the hippocampus and the cerebellar cortex, P2Y receptors activate inhibitory GABAergic interneurons playing a key role in timing and organization of principal cell firing. The modulatory effects of P2Y receptors on membrane channels and receptors are sufficient to influence synaptic transmission and plasticity which may sustainably affect the connectivity between different excitatory and inhibitory cell types and thus the network activity in different brain areas. Therefore, P2Y receptors represent important pharmacological targets to treat cognitive dysfunctions and neuropsychiatric diseases, such as Alzheimer’s disease and schizophrenia.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

References

  1. C. H. Fiske and Y. SubbaRow, “Phosphorus compounds of muscle and liver,” Science, vol. 70, no. 1816, pp. 381–382, 1929. View at Google Scholar · View at Scopus
  2. K. Lohman, “Über die Pyrophosphatfraktion im Muskel,” Naturwissenschaften, vol. 17, pp. 624–625, 1929. View at Google Scholar
  3. A. N. Drury and A. Szent-Györgyi, “The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart,” The Journal of Physiology, vol. 68, no. 3, pp. 213–237, 1929. View at Publisher · View at Google Scholar
  4. G. Burnstock, “Historical review: ATP as a neurotransmitter,” Trends in Pharmacological Sciences, vol. 27, no. 3, pp. 166–176, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Burnstock, “Purinergic nerves,” Pharmacological Reviews, vol. 24, no. 3, pp. 509–581, 1972. View at Google Scholar · View at Scopus
  6. G. Burnstock, “Purinergic receptors,” Journal of Theoretical Biology, vol. 62, no. 2, pp. 491–503, 1976. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Burnstock and C. Kennedy, “Is there a basis for distinguishing two types of P2-purinoceptor?” General Pharmacology, vol. 16, no. 5, pp. 433–440, 1985. View at Publisher · View at Google Scholar · View at Scopus
  8. H. A. Kolb and M. J. O. Wakelam, “Transmitter-like action of ATP on patched membranes of cultured myoblasts and myotubes,” Nature, vol. 303, no. 5918, pp. 621–623, 1983. View at Publisher · View at Google Scholar · View at Scopus
  9. C. D. Benham and R. W. Tsien, “A novel receptor-operated Ca2+-permeable channel activated by ATP in smooth muscle,” Nature, vol. 328, no. 6127, pp. 275–278, 1987. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Charest, P. F. Blackmore, and J. H. Exton, “Characterization of responses of isolated rat hepatocytes to ATP and ADP,” The Journal of Biological Chemistry, vol. 260, no. 29, pp. 15789–15794, 1985. View at Google Scholar · View at Scopus
  11. J. L. Boyer, G. L. Waldo, T. Evans, J. K. Northup, C. P. Downes, and T. K. Harden, “Modification of AlF-4- and receptor-stimulated phospholipase C activity by G-protein beta gamma subunits,” The Journal of Biological Chemistry, vol. 264, no. 23, pp. 13917–13922, 1989. View at Google Scholar
  12. I. von Kügelgen and K. Hoffmann, “Pharmacology and structure of P2Y receptors,” Neuropharmacology, 2015. View at Publisher · View at Google Scholar
  13. M. P. Abbracchio, G. Burnstock, J.-M. Boeynaems et al., “International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy,” Pharmacological Reviews, vol. 58, no. 3, pp. 281–341, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Erb, Z. Liao, C. I. Seye, and G. A. Weisman, “P2 receptors: intracellular signaling,” Pflügers Archiv, vol. 452, no. 5, pp. 552–562, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. T. D. Nguyen, S. Meichle, U. S. Kim, T. Wong, and M. W. Moody, “P2Y11, a purinergic receptor acting via cAMP, mediates secretion by pancreatic duct epithelial cells,” The American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 280, no. 5, pp. G795–G804, 2001. View at Google Scholar · View at Scopus
  16. G. Burnstock and G. E. Knight, “Cellular distribution and functions of P2 receptor subtypes in different systems,” International Review of Cytology, vol. 240, pp. 31–304, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. P. B. Guthrie, J. Knappenberger, M. Segal, M. V. L. Bennett, A. C. Charles, and S. B. Kater, “ATP released from astrocytes mediates glial calcium waves,” The Journal of Neuroscience, vol. 19, no. 2, pp. 520–528, 1999. View at Google Scholar · View at Scopus
  18. R. D. Fields and G. Burnstock, “Purinergic signalling in neuron-glia interactions,” Nature Reviews Neuroscience, vol. 7, no. 6, pp. 423–436, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. S. K. Mishra, N. Braun, V. Shukla et al., “Extracellular nucleotide signaling in adult neural stem cells: synergism with growth factor-mediated cellular proliferation,” Development, vol. 133, no. 4, pp. 675–684, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. G. A. Weisman, L. T. Woods, L. Erb, and C. I. Seye, “P2Y receptors in the mammalian nervous system: pharmacology, ligands and therapeutic potential,” CNS & Neurological Disorders—Drug Targets, vol. 11, no. 6, pp. 722–738, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Franke and P. Illes, “Involvement of P2 receptors in the growth and survival of neurons in the CNS,” Pharmacology and Therapeutics, vol. 109, no. 3, pp. 297–324, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Kuboyama, H. Harada, H. Tozaki-Saitoh, M. Tsuda, K. Ushijima, and K. Inoue, “Astrocytic P2Y1 receptor is involved in the regulation of cytokine/chemokine transcription and cerebral damage in a rat model of cerebral ischemia,” Journal of Cerebral Blood Flow and Metabolism, vol. 31, no. 9, pp. 1930–1941, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. Z. Gerevich, C. Müller, and P. Illes, “Metabotropic P2Y1 receptors inhibit P2X3 receptor-channels in rat dorsal root ganglion neurons,” European Journal of Pharmacology, vol. 521, no. 1–3, pp. 34–38, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. Z. Gerevich, Z. Zadori, C. Müller et al., “Metabotropic P2Y receptors inhibit P2X3 receptor-channels via G protein-dependent facilitation of their desensitization,” British Journal of Pharmacology, vol. 151, no. 2, pp. 226–236, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. Z. Gerevich and P. Illes, “P2Y receptors and pain transmission,” Purinergic Signalling, vol. 1, no. 1, pp. 3–10, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Burnstock and A. Verkhratsky, “Long-term (trophic) purinergic signalling: purinoceptors control cell proliferation, differentiation and death,” Cell Death and Disease, vol. 1, article e9, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Idzko, D. Ferrari, and H. K. Eltzschig, “Nucleotide signalling during inflammation,” Nature, vol. 509, no. 7500, pp. 310–317, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Pankratov, U. Lalo, A. Verkhratsky, and R. A. North, “Vesicular release of ATP at central synapses,” Pflügers Archiv, vol. 452, no. 5, pp. 589–597, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. R. D. Fields, “Nonsynaptic and nonvesicular ATP release from neurons and relevance to neuron-glia signaling,” Seminars in Cell and Developmental Biology, vol. 22, no. 2, pp. 214–219, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. P. Bezzi and A. Volterra, “A neuron-glia signalling network in the active brain,” Current Opinion in Neurobiology, vol. 11, no. 3, pp. 387–394, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Imura, Y. Morizawa, R. Komatsu et al., “Microglia release ATP by exocytosis,” Glia, vol. 61, no. 8, pp. 1320–1330, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. J. George, F. Q. Gonçalves, G. Cristóvão et al., “Different danger signals differently impact on microglial proliferation through alterations of ATP release and extracellular metabolism,” Glia, vol. 63, no. 9, pp. 1636–1645, 2015. View at Publisher · View at Google Scholar
  33. A. Bal-Price, Z. Moneer, and G. C. Brown, “Nitric oxide induces rapid, calcium-dependent release of vesicular glutamate and ATP from cultured rat astrocytes,” Glia, vol. 40, no. 3, pp. 312–323, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. T. D. Montero and J. A. Orellana, “Hemichannels: new pathways for gliotransmitter release,” Neuroscience, vol. 286, pp. 45–59, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Duan, C. M. Anderson, E. C. Keung, Y. Chen, Y. Chen, and R. A. Swanson, “P2X7 receptor-mediated release of excitatory amino acids from astrocytes,” Journal of Neuroscience, vol. 23, no. 4, pp. 1320–1328, 2003. View at Google Scholar · View at Scopus
  36. T. V. Dunwiddie, L. Diao, and W. R. Proctor, “Adenine nucleotides undergo rapid, quantitative conversion to adenosine in the extracellular space in rat hippocampus,” Journal of Neuroscience, vol. 17, no. 20, pp. 7673–7682, 1997. View at Google Scholar · View at Scopus
  37. H. Zimmermann, “Ectonucleotidases in the nervous system,” Novartis Foundation Symposium, vol. 276, pp. 113–128, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. F. A. Edwards, A. J. Gibb, and D. Colquhoun, “ATP receptor-mediated synaptic currents in the central nervous system,” Nature, vol. 359, no. 6391, pp. 144–147, 1992. View at Publisher · View at Google Scholar · View at Scopus
  39. R. J. Evans, V. Derkach, and A. Surprenant, “ATP mediates fast synaptic transmission in mammalian neurons,” Nature, vol. 357, no. 6378, pp. 503–505, 1992. View at Publisher · View at Google Scholar · View at Scopus
  40. E. M. Silinsky, V. Gerzanich, and S. M. Vanner, “ATP mediates excitatory synaptic transmission in mammalian neurones,” British Journal of Pharmacology, vol. 106, no. 4, pp. 762–763, 1992. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. Pankratov, E. Castro, M. T. Miras-Portugal, and O. Krishtal, “A purinergic component of the excitatory postsynaptic current mediated by P2X receptors in the CA1 neurons of the rat hippocampus,” European Journal of Neuroscience, vol. 10, no. 12, pp. 3898–3902, 1998. View at Publisher · View at Google Scholar · View at Scopus
  42. B. S. Khakh and R. A. North, “Neuromodulation by extracellular ATP and P2X Receptors in the CNS,” Neuron, vol. 76, no. 1, pp. 51–69, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. B. Sperlágh, A. Heinrich, and C. Csöllle, “P2 receptor-mediated modulation of neurotransmitter release-an update,” Purinergic Signalling, vol. 3, no. 4, pp. 269–284, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. H. Koch, A. Bespalov, K. Drescher, H. Franke, and U. Krügel, “Impaired cognition after stimulation of P2Y1 receptors in the rat medial prefrontal cortex,” Neuropsychopharmacology, vol. 40, pp. 305–314, 2015. View at Google Scholar
  45. Z. Gerevich, S. J. Borvendeg, W. Schröder et al., “Inhibition of N-type voltage-activated calcium channels in rat dorsal root ganglion neurons by P2Y receptors is a possible mechanism of ADP-induced analgesia,” Journal of Neuroscience, vol. 24, no. 4, pp. 797–807, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Heinrich, Á. Kittel, C. Csölle, E. Sylvester Vizi, and B. Sperlágh, “Modulation of neurotransmitter release by P2X and P2Y receptors in the rat spinal cord,” Neuropharmacology, vol. 54, no. 2, pp. 375–386, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. V. Mendoza-Fernandez, R. D. Andrew, and C. Barajas-López, “ATP inhibits glutamate synaptic release by acting at P2Y receptors in pyramidal neurons of hippocampal slices,” Journal of Pharmacology and Experimental Therapeutics, vol. 293, no. 1, pp. 172–179, 2000. View at Google Scholar · View at Scopus
  48. R. J. Rodrigues, T. Almeida, P. J. Richardson, C. R. Oliveira, and R. A. Cunha, “Dual presynaptic control by ATP of glutamate release via facilitatory P2X1, P2X2/3, and P2X3 and inhibitory P2Y1, P2Y2, and/or P2Y4 receptors in the rat hippocampus,” Journal of Neuroscience, vol. 25, no. 27, pp. 6286–6295, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Koizumi, K. Fujishita, M. Tsuda, Y. Shigemoto-Mogami, and K. Inoue, “Dynamic inhibition of excitatory synaptic transmission by astrocyte-derived ATP in hippocampal cultures,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 19, pp. 11023–11028, 2003. View at Publisher · View at Google Scholar · View at Scopus
  50. G. C. Bennett and M. R. Boarder, “The effect of nucleotides and adenosine on stimulus-evoked glutamate release from rat brain cortical slices,” British Journal of Pharmacology, vol. 131, no. 3, pp. 617–623, 2000. View at Publisher · View at Google Scholar · View at Scopus
  51. A. K. Filippov, T. E. Webb, E. A. Barnard, and D. A. Brown, “Inhibition by heterologously-expressed P2Y2 nucleotide receptors of N-type calcium currents in rat sympathetic neurones,” British Journal of Pharmacology, vol. 121, no. 5, pp. 849–851, 1997. View at Publisher · View at Google Scholar · View at Scopus
  52. R. Donato, R. J. Rodrigues, M. Takahashi et al., “GABA release by basket cells onto Purkinje cells, in rat cerebellar slices, is directly controlled by presynaptic purinergic receptors, modulating Ca2+ influx,” Cell Calcium, vol. 44, no. 6, pp. 521–532, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. H. Koch, I. von Kügelgen, and K. Starke, “P2-Receptor-mediated inhibition of noradrenaline release in the rat hippocampus,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 355, no. 6, pp. 707–715, 1997. View at Publisher · View at Google Scholar · View at Scopus
  54. C. Csölle, A. Heinrich, Á. Kittel, and B. Sperlágh, “P2Y receptor mediated inhibitory modulation of noradrenaline release in response to electrical field stimulation and ischemic conditions in superfused rat hippocampus slices,” Journal of Neurochemistry, vol. 106, no. 1, pp. 347–360, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. I. von Kügelgen, K. Kurz, and K. Starke, “P2-purinoceptor-mediated autoinhibition of sympathetic transmitter release in mouse and rat vas deferens,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 349, no. 2, pp. 125–132, 1994. View at Publisher · View at Google Scholar · View at Scopus
  56. S. G. Lechner, M. M. Dorostkar, M. Mayer, H. Edelbauer, H. Pankevych, and S. Boehm, “Autoinhibition of transmitter release from PC12 cells and sympathetic neurons through a P2Y12 receptor-mediated inhibition of voltage-gated Ca2+ channels,” European Journal of Neuroscience, vol. 20, no. 11, pp. 2917–2928, 2004. View at Publisher · View at Google Scholar · View at Scopus
  57. I. von Kügelgen, H. Koch, and K. Starke, “P2-receptor-mediated inhibition of serotonin release in the rat brain cortex,” Neuropharmacology, vol. 36, no. 9, pp. 1221–1227, 1997. View at Publisher · View at Google Scholar
  58. Y.-X. Zhang, H. Yamashita, T. Ohshita, N. Sawamoto, and S. Nakamura, “ATP increases extracellular dopamine level through stimulation of P2Y purinoceptors in the rat striatum,” Brain Research, vol. 691, no. 1-2, pp. 205–212, 1995. View at Publisher · View at Google Scholar · View at Scopus
  59. A. U. Trendelenburg and R. Bültmann, “P2 receptor-mediated inhibition of dopamine release in rat neostriatum,” Neuroscience, vol. 96, no. 2, pp. 249–252, 2000. View at Publisher · View at Google Scholar · View at Scopus
  60. U. Krügel, H. Kittner, H. Franke, and P. Illes, “Stimulation of P2 receptors in the ventral tegmental area enhances dopaminergic mechanisms in vivo,” Neuropharmacology, vol. 40, no. 8, pp. 1084–1093, 2001. View at Publisher · View at Google Scholar · View at Scopus
  61. L. Köles, Z. Gerevich, J. F. Oliveira, Z. S. Zadori, K. Wirkner, and P. Illes, “Interaction of P2 purinergic receptors with cellular macromolecules,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 377, no. 1, pp. 1–33, 2008. View at Publisher · View at Google Scholar · View at Scopus
  62. S. J. Mundell, G. Pula, R. A. J. McIlhinney, P. J. Roberts, and E. Kelly, “Desensitization and internalization of metabotropic glutamate receptor 1a following activation of heterologous Gq/11-coupled receptors,” Biochemistry, vol. 43, no. 23, pp. 7541–7551, 2004. View at Publisher · View at Google Scholar · View at Scopus
  63. J. Luthardt, S. J. Borvendeg, B. Sperlagh, W. Poelchen, K. Wirkner, and P. Illes, “P2Y1 receptor activation inhibits NMDA receptor-channels in layer V pyramidal neurons of the rat prefrontal and parietal cortex,” Neurochemistry International, vol. 42, no. 2, pp. 161–172, 2003. View at Publisher · View at Google Scholar · View at Scopus
  64. S. J. Guzman, Z. Gerevich, J. G. Hengstler, P. Illes, and W. Kleemann, “P2Y1 receptors inhibit both strength and plasticity of glutamatergic synaptic neurotransmission in the rat prefrontal cortex,” Synapse, vol. 57, no. 4, pp. 235–238, 2005. View at Publisher · View at Google Scholar · View at Scopus
  65. K. Wirkner, A. Günther, M. Weber et al., “Modulation of NMDA receptor current in layer V pyramidal neurons of the rat prefrontal cortex by P2Y receptor activation,” Cerebral Cortex, vol. 17, no. 3, pp. 621–631, 2007. View at Publisher · View at Google Scholar · View at Scopus
  66. F. Saitow, T. Murakoshi, H. Suzuki, and S. Konishi, “Metabotropic P2Y purinoceptor-mediated presynaptic and postsynaptic enhancement of cerebellar GABAergic transmission,” Journal of Neuroscience, vol. 25, no. 8, pp. 2108–2116, 2005. View at Publisher · View at Google Scholar · View at Scopus
  67. M. Tominaga, M. Wada, and M. Masu, “Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possible mechanism for ATP-evoked pain and hyperalgesia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 12, pp. 6951–6956, 2001. View at Publisher · View at Google Scholar · View at Scopus
  68. T. Moriyama, T. Iida, K. Kobayashi et al., “Possible involvement of P2Y2 metabotropic receptors in ATP-induced transient receptor potential vanilloid receptor 1-mediated thermal hypersensitivity,” Journal of Neuroscience, vol. 23, no. 14, pp. 6058–6062, 2003. View at Google Scholar · View at Scopus
  69. S. Lakshmi and P. G. Joshi, “Co-activation of P2Y2 receptor and TRPV channel by ATP: implications for ATP induced pain,” Cellular and Molecular Neurobiology, vol. 25, no. 5, pp. 819–832, 2005. View at Publisher · View at Google Scholar · View at Scopus
  70. J. A. Kauer and H. E. Gibson, “Hot flash: TRPV channels in the brain,” Trends in Neurosciences, vol. 32, no. 4, pp. 215–224, 2009. View at Publisher · View at Google Scholar · View at Scopus
  71. H. E. Gibson, J. G. Edwards, R. S. Page, M. J. Van Hook, and J. A. Kauer, “TRPV1 channels mediate long-term depression at synapses on hippocampal interneurons,” Neuron, vol. 57, no. 5, pp. 746–759, 2008. View at Publisher · View at Google Scholar · View at Scopus
  72. P. Paoletti, C. Bellone, and Q. Zhou, “NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease,” Nature Reviews Neuroscience, vol. 14, no. 6, pp. 383–400, 2013. View at Publisher · View at Google Scholar · View at Scopus
  73. S. G. Lechner and S. Boehm, “Regulation of neuronal ion channels via P2Y receptors,” Purinergic Signalling, vol. 1, no. 1, pp. 31–41, 2004. View at Publisher · View at Google Scholar · View at Scopus
  74. M. Dlverse-Plerluissi, K. Dunlap, and E. W. Westhead, “Multiple actions of extracellular ATP on calcium currents in cultured bovine chromaffin cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 4, pp. 1261–1265, 1991. View at Publisher · View at Google Scholar · View at Scopus
  75. A. K. Filippov, T. E. Webb, E. A. Barnard, and D. A. Brown, “Dual coupling of heterologously-expressed rat P2Y6 nucleotide receptors to N-type Ca2+ and M-type K+ currents in rat sympathetic neurones,” British Journal of Pharmacology, vol. 126, no. 4, pp. 1009–1017, 1999. View at Publisher · View at Google Scholar · View at Scopus
  76. A. K. Filippov, D. A. Brown, and E. A. Barnard, “The P2Y1 receptor closes the N-type Ca2+ channel in neurones, with both adenosine triphosphates and diphosphates as potent agonists,” British Journal of Pharmacology, vol. 129, no. 6, pp. 1063–1066, 2000. View at Publisher · View at Google Scholar · View at Scopus
  77. A. K. Filippov, J. Simon, E. A. Barnard, and D. A. Brown, “Coupling of the nucleotide P2Y4 receptor to neuronal ion channels,” British Journal of Pharmacology, vol. 138, no. 2, pp. 400–406, 2003. View at Publisher · View at Google Scholar · View at Scopus
  78. K. Wirkner, J. Schweigel, Z. Gerevich et al., “Adenine nucleotides inhibit recombinant N-type calcium channels via G protein-coupled mechanisms in HEK 293 cells; involvement of the P2Y 13 receptor-type,” British Journal of Pharmacology, vol. 141, no. 1, pp. 141–151, 2004. View at Publisher · View at Google Scholar · View at Scopus
  79. S. J. Borvendeg, Z. Gerevich, C. Gillen, and P. Illes, “P2Y receptor-mediated inhibition of voltage-dependent Ca2+ channels in rat dorsal root ganglion neurons,” Synapse, vol. 47, no. 2, pp. 159–161, 2003. View at Publisher · View at Google Scholar · View at Scopus
  80. M. Abe, T. Endoh, and T. Suzuki, “Extracellular ATP-induced calcium channel inhibition mediated by P1/P2Y purinoceptors in hamster submandibular ganglion neurons,” British Journal of Pharmacology, vol. 138, no. 8, pp. 1535–1543, 2003. View at Publisher · View at Google Scholar · View at Scopus
  81. Y. Qu, D. L. Campbell, and H. C. Strauss, “Modulation of L-type Ca2+ current by extracellular ATP in ferret isolated right ventricular myocytes,” Journal of Physiology, vol. 471, pp. 295–317, 1993. View at Publisher · View at Google Scholar · View at Scopus
  82. Q. Gong, M. Kakei, N. Koriyama et al., “P2Y-purinoceptor mediated inhibition of L-type Ca2+ channels in rat pancreatic β-cells,” Cell Structure and Function, vol. 25, no. 5, pp. 279–289, 2000. View at Publisher · View at Google Scholar · View at Scopus
  83. K. P. Monaghan, D. K. Sang, S. Ro, J. Yeom, B. Horowitz, and K. M. Sanders, “Nucleotide regulation of the voltage-dependent nonselective cation conductance in murine colonic myocytes,” American Journal of Physiology—Cell Physiology, vol. 291, no. 5, pp. C985–C994, 2006. View at Publisher · View at Google Scholar · View at Scopus
  84. B. A. Simms and G. W. Zamponi, “Neuronal voltage-gated calcium channels: structure, function, and dysfunction,” Neuron, vol. 82, no. 1, pp. 24–45, 2014. View at Publisher · View at Google Scholar · View at Scopus
  85. G. A. Gutman, K. G. Chandy, S. Grissmer et al., “International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels,” Pharmacological Reviews, vol. 57, no. 4, pp. 473–508, 2005. View at Publisher · View at Google Scholar · View at Scopus
  86. H. S. Lopez and P. R. Adams, “A G protein mediates the inhibition of the voltage-dependent potassium M current by muscarine, LHRH, substance P and UTP in bullfrog sympathetic neurons,” European Journal of Neuroscience, vol. 1, no. 5, pp. 529–542, 1989. View at Publisher · View at Google Scholar · View at Scopus
  87. K. Nakazawa, K. Inoue, and K. Inoue, “ATP reduces voltage-activated K+ current in cultured rat hippocampal neurons,” Pflugers Archiv, vol. 429, no. 1, pp. 143–145, 1994. View at Publisher · View at Google Scholar · View at Scopus
  88. S. Boehm, “Selective inhibition of M-type potassium channels in rat sympathetic neurons by uridine nucleotide preferring receptors,” British Journal of Pharmacology, vol. 124, no. 6, pp. 1261–1269, 1998. View at Publisher · View at Google Scholar · View at Scopus
  89. A. K. Filippov, R. C. Y. Choi, J. Simon, E. A. Barnard, and D. A. Brown, “Activation of P2Y1 nucleotide receptors induces inhibition of the M-type K+ current in rat hippocampal pyramidal neurons,” Journal of Neuroscience, vol. 26, no. 36, pp. 9340–9348, 2006. View at Publisher · View at Google Scholar · View at Scopus
  90. D. A. Brown and G. M. Passmore, “Neural KCNQ (Kv7) channels,” British Journal of Pharmacology, vol. 156, no. 8, pp. 1185–1195, 2009. View at Publisher · View at Google Scholar · View at Scopus
  91. C. Lüscher and P. A. Slesinger, “Emerging roles for G protein-gated inwardly rectifying potassium (GIRK) channels in health and disease,” Nature Reviews Neuroscience, vol. 11, no. 5, pp. 301–315, 2010. View at Publisher · View at Google Scholar · View at Scopus
  92. H. Matsuura and T. Ehara, “Modulation of the muscarinic K+ channel by P2-purinoceptors in guinea-pig atrial myocytes,” Journal of Physiology, vol. 497, no. 2, pp. 379–393, 1996. View at Publisher · View at Google Scholar · View at Scopus
  93. M. D. Mark, J. P. Ruppersberg, and S. Herlitze, “Regulation of GIRK channel deactivation by Gα(q) and Gα(i/o) pathways,” Neuropharmacology, vol. 39, no. 12, pp. 2360–2373, 2000. View at Publisher · View at Google Scholar · View at Scopus
  94. G. Hollopeter, H.-M. Jantzen, D. Vincent et al., “Identification of the platelet ADP receptor targeted by antithrombotic drugs,” Nature, vol. 409, no. 6817, pp. 202–207, 2001. View at Publisher · View at Google Scholar · View at Scopus
  95. J. Simon, A. K. Filippov, S. Göransson et al., “Characterization and channel coupling of the P2Y12 nucleotide receptor of brain capillary endothelial cells,” The Journal of Biological Chemistry, vol. 277, no. 35, pp. 31390–31400, 2002. View at Publisher · View at Google Scholar · View at Scopus
  96. A. K. Filippov, J. M. Fernández-Fernández, S. J. Marsh, J. Simon, E. A. Barnard, and D. A. Brown, “Activation and inhibition of neuronal G protein-gated inwardly rectifying K+ channels by P2Y nucleotide receptors,” Molecular Pharmacology, vol. 66, no. 3, pp. 468–477, 2004. View at Google Scholar · View at Scopus
  97. Y. Yamashita, H. Ogawa, and N. Akaike, “ATP-induced rise in apamin-sensitive Ca2+-dependent K+ conductance in adult rat hepatocytes,” The American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 270, no. 2, pp. G307–G313, 1996. View at Google Scholar · View at Scopus
  98. A. Bringmann, T. Pannicke, M. Weick et al., “Activation of P2Y receptors stimulates potassium and cation currents in acutely isolated human Müller (glial) cells,” Glia, vol. 37, no. 2, pp. 139–152, 2002. View at Publisher · View at Google Scholar · View at Scopus
  99. K. W. Schicker, G. K. Chandaka, P. Geier, H. Kubista, and S. Boehm, “P2Y1 receptors mediate an activation of neuronal calcium-dependent K+ channels,” Journal of Physiology, vol. 588, no. 19, pp. 3713–3725, 2010. View at Publisher · View at Google Scholar · View at Scopus
  100. E. Coppi, F. Pedata, and A. J. Gibb, “P2Y1 receptor modulation of Ca2+-activated K+ currents in medium-sized neurons from neonatal rat striatal slices,” Journal of Neurophysiology, vol. 107, no. 3, pp. 1009–1021, 2012. View at Publisher · View at Google Scholar · View at Scopus
  101. D. Moore, J. Chambers, H. Waldvogel, R. Faull, and P. Emson, “Regional and cellular distribution of the P2Y1 purinergic receptor in the human brain: Striking nearonal localisation,” Journal of Comparative Neurology, vol. 421, no. 3, pp. 374–384, 2000. View at Publisher · View at Google Scholar · View at Scopus
  102. M.-J. Morán-Jiménez and C. Matute, “Immunohistochemical localization of the P2Y1 purinergic receptor in neurons and glial cells of the central nervous system,” Molecular Brain Research, vol. 78, no. 1-2, pp. 50–58, 2000. View at Publisher · View at Google Scholar · View at Scopus
  103. M. Kawamura, C. Gachet, K. Inoue, and F. Kato, “Direct excitation of inhibitory interneurons by extracellular ATP mediated by P2Y1 receptors in the hippocampal slice,” Journal of Neuroscience, vol. 24, no. 48, pp. 10835–10845, 2004. View at Publisher · View at Google Scholar · View at Scopus
  104. D. N. Bowser and B. S. Khakh, “ATP excites interneurons and astrocytes to increase synaptic inhibition in neuronal networks,” Journal of Neuroscience, vol. 24, no. 39, pp. 8606–8620, 2004. View at Publisher · View at Google Scholar · View at Scopus
  105. J. Brockhaus, D. Dressel, S. Herold, and J. W. Deitmer, “Purinergic modulation of synaptic input to Purkinje neurons in rat cerebellar brain slices,” European Journal of Neuroscience, vol. 19, no. 8, pp. 2221–2230, 2004. View at Publisher · View at Google Scholar · View at Scopus
  106. J. Deitmer, J. Brockhaus, and D. Casel, “Modulation of synaptic activity in Purkinje neurons by ATP,” Cerebellum, vol. 5, no. 1, pp. 49–54, 2006. View at Publisher · View at Google Scholar · View at Scopus
  107. M. Farrant and Z. Nusser, “Variations on an inhibitory theme: phasic and tonic activation of GABAA receptors,” Nature Reviews Neuroscience, vol. 6, no. 3, pp. 215–229, 2005. View at Publisher · View at Google Scholar · View at Scopus
  108. A. Kepecs and G. Fishell, “Interneuron cell types are fit to function,” Nature, vol. 505, no. 7483, pp. 318–326, 2014. View at Publisher · View at Google Scholar · View at Scopus
  109. T. F. Freund and G. Buzsáki, “Interneurons of the hippocampus,” Hippocampus, vol. 6, no. 4, pp. 347–470, 1996. View at Google Scholar · View at Scopus
  110. T. Klausberger and P. Somogyi, “Neuronal diversity and temporal dynamics: the unity of hippocampal circuit operations,” Science, vol. 321, no. 5885, pp. 53–57, 2008. View at Publisher · View at Google Scholar · View at Scopus
  111. J. Defelipe, P. L. López-Cruz, R. Benavides-Piccione et al., “New insights into the classification and nomenclature of cortical GABAergic interneurons,” Nature Reviews Neuroscience, vol. 14, no. 3, pp. 202–216, 2013. View at Publisher · View at Google Scholar · View at Scopus
  112. S. B. Schulz, Z.-J. Klaft, A. R. Rösler, U. Heinemann, and Z. Gerevich, “Purinergic P2X, P2Y and adenosine receptors differentially modulate hippocampal gamma oscillations,” Neuropharmacology, vol. 62, no. 2, pp. 914–924, 2012. View at Publisher · View at Google Scholar · View at Scopus
  113. M. Bartos, I. Vida, and P. Jonas, “Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks,” Nature Reviews Neuroscience, vol. 8, no. 1, pp. 45–56, 2007. View at Publisher · View at Google Scholar · View at Scopus
  114. Z.-J. Klaft, S. B. Schulz, A. Maslarova, S. Gabriel, U. Heinemann, and Z. Gerevich, “Extracellular ATP differentially affects epileptiform activity via purinergic P2X7 and adenosine A1 receptors in naive and chronic epileptic rats,” Epilepsia, vol. 53, no. 11, pp. 1978–1986, 2012. View at Publisher · View at Google Scholar · View at Scopus
  115. P. Fries, “Neuronal gamma-band synchronization as a fundamental process in cortical computation,” Annual Review of Neuroscience, vol. 32, pp. 209–224, 2009. View at Publisher · View at Google Scholar · View at Scopus
  116. C. S. Herrmann and T. Demiralp, “Human EEG gamma oscillations in neuropsychiatric disorders,” Clinical Neurophysiology, vol. 116, no. 12, pp. 2719–2733, 2005. View at Publisher · View at Google Scholar · View at Scopus
  117. P. J. Uhlhaas and W. Singer, “Neuronal dynamics and neuropsychiatric disorders: toward a translational paradigm for dysfunctional large-scale networks,” Neuron, vol. 75, no. 6, pp. 963–980, 2012. View at Publisher · View at Google Scholar · View at Scopus
  118. A. Posłuszny, “The contribution of electrical synapses to field potential oscillations in the hippocampal formation,” Frontiers in Neural Circuits, vol. 8, article 32, 2014. View at Publisher · View at Google Scholar · View at Scopus
  119. C. E. Stout, J. L. Costantin, C. C. G. Naus, and A. C. Charles, “Intercellular calcium signaling in astrocytes via ATP release through connexin hemichannels,” The Journal of Biological Chemistry, vol. 277, no. 12, pp. 10482–10488, 2002. View at Publisher · View at Google Scholar · View at Scopus
  120. S. Locovei, J. Wang, and G. Dahl, “Activation of pannexin 1 channels by ATP through P2Y receptors and by cytoplasmic calcium,” FEBS Letters, vol. 580, no. 1, pp. 239–244, 2006. View at Publisher · View at Google Scholar · View at Scopus
  121. A. Araque, V. Parpura, R. P. Sanzgiri, and P. G. Haydon, “Tripartite synapses: glia, the unacknowledged partner,” Trends in Neurosciences, vol. 22, no. 5, pp. 208–215, 1999. View at Publisher · View at Google Scholar · View at Scopus
  122. A. Araque, G. Carmignoto, P. G. Haydon, S. H. R. Oliet, R. Robitaille, and A. Volterra, “Gliotransmitters travel in time and space,” Neuron, vol. 81, no. 4, pp. 728–739, 2014. View at Publisher · View at Google Scholar · View at Scopus
  123. V. Gundersen, J. Storm-Mathisen, and L. H. Bergersen, “Neuroglial transmission,” Physiological Reviews, vol. 95, no. 3, pp. 695–726, 2015. View at Publisher · View at Google Scholar
  124. R. Káradóttir, P. Cavelier, L. H. Bergersen, and D. Attwell, “NMDA receptors are expressed in oligodendrocytes and activated in ischaemia,” Nature, vol. 438, no. 7071, pp. 1162–1166, 2005. View at Publisher · View at Google Scholar · View at Scopus
  125. C. J. L. Sogn, M. Puchades, and V. Gundersen, “Rare contacts between synapses and microglial processes containing high levels of Iba1 and actin—a postembedding immunogold study in the healthy rat brain,” European Journal of Neuroscience, vol. 38, no. 1, pp. 2030–2040, 2013. View at Publisher · View at Google Scholar · View at Scopus
  126. J. T. Porter and K. D. McCarthy, “Hippocampal astrocytes in situ respond to glutamate released from synaptic terminals,” Journal of Neuroscience, vol. 16, no. 16, pp. 5073–5081, 1996. View at Google Scholar · View at Scopus
  127. O. Pascual, K. B. Casper, C. Kubera et al., “Astrocytic purinergic signaling coordinates synaptic networks,” Science, vol. 310, no. 5745, pp. 113–116, 2005. View at Publisher · View at Google Scholar · View at Scopus
  128. S. Koizumi, “Synchronization of Ca2+ oscillations: involvement of ATP release in astrocytes,” FEBS Journal, vol. 277, no. 2, pp. 286–292, 2010. View at Publisher · View at Google Scholar · View at Scopus
  129. E. S. Vizi, Non-Synaptic Interactions between Neurons: Modulation of Neurochemical Transmission, John Wiley & Sons, London, UK, 1984.
  130. L. F. Agnati, D. Guidolin, M. Guescini, S. Genedani, and K. Fuxe, “Understanding wiring and volume transmission,” Brain Research Reviews, vol. 64, no. 1, pp. 137–159, 2010. View at Publisher · View at Google Scholar · View at Scopus
  131. Y. Yamazaki, K. Kaneko, S. Fujii, H. Kato, and K.-I. Ito, “Long-term potentiation and long-term depression induced by local application of ATP to hippocampal CA1 neurons of the guinea pig,” Hippocampus, vol. 13, no. 1, pp. 81–92, 2003. View at Publisher · View at Google Scholar · View at Scopus
  132. S. Fujii, “ATP- and adenosine-mediated signaling in the central nervous system: the role of extracellular ATP in hippocampal long-term potentiation,” Journal of Pharmacological Sciences, vol. 94, no. 2, pp. 103–106, 2004. View at Publisher · View at Google Scholar · View at Scopus
  133. H. Ikeda, M. Tsuda, K. Inoue, and K. Murase, “Long-term potentiation of neuronal excitation by neuron-glia interactions in the rat spinal dorsal horn,” European Journal of Neuroscience, vol. 25, no. 5, pp. 1297–1306, 2007. View at Publisher · View at Google Scholar · View at Scopus
  134. J. A. Sim, S. Chaumont, J. Jo et al., “Altered hippocampal synaptic potentiation in P2X4 knock-out mice,” Journal of Neuroscience, vol. 26, no. 35, pp. 9006–9009, 2006. View at Publisher · View at Google Scholar · View at Scopus
  135. J.-T. Pougnet, E. Toulme, A. Martinez, D. Choquet, E. Hosy, and E. Boué-Grabot, “ATP P2X receptors downregulate AMPA receptor trafficking and postsynaptic efficacy in hippocampal neurons,” Neuron, vol. 83, no. 2, pp. 417–430, 2014. View at Publisher · View at Google Scholar · View at Scopus
  136. Y. Pankratov, U. Lalo, O. A. Krishtal, and A. Verkhratsky, “P2X receptors and synaptic plasticity,” Neuroscience, vol. 158, no. 1, pp. 137–148, 2009. View at Publisher · View at Google Scholar · View at Scopus
  137. Y. Yamazaki, S. Fujii, T. Nakamura et al., “Changes in Ca2+i during adenosine triphosphate-induced synaptic plasticity in hippocampal CA1 neurons of the guinea pig,” Neuroscience Letters, vol. 324, no. 1, pp. 65–68, 2002. View at Publisher · View at Google Scholar · View at Scopus
  138. Y. V. Pankratov, U. V. Lalo, and O. A. Krishtal, “Role for P2X receptors in long-term potentiation,” Journal of Neuroscience, vol. 22, no. 19, pp. 8363–8369, 2002. View at Google Scholar · View at Scopus
  139. Y. Wang, J. Mackes, S. Chan et al., “Impaired long-term depression in P2X3 deficient mice is not associated with a spatial learning deficit,” Journal of Neurochemistry, vol. 99, no. 5, pp. 1425–1434, 2006. View at Publisher · View at Google Scholar · View at Scopus
  140. Y. Wang, N. J. Haughey, M. P. Mattson, and K. Furukawa, “Dual effects of ATP on rat hippocampal synaptic plasticity,” NeuroReport, vol. 15, no. 4, pp. 633–636, 2004. View at Publisher · View at Google Scholar · View at Scopus
  141. H. Viswanath, A. Q. Carter, P. R. Baldwin, D. L. Molfese, and R. Salas, “The medial habenula: still neglected,” Frontiers in Human Neuroscience, vol. 7, article 931, 2014. View at Publisher · View at Google Scholar
  142. G. D. Price, S. J. Robertson, and F. A. Edwards, “Long-term potentiation of glutamatergic synaptic transmission induced by activation of presynaptic P2Y receptors in the rat medial habenula nucleus,” European Journal of Neuroscience, vol. 17, no. 4, pp. 844–850, 2003. View at Publisher · View at Google Scholar · View at Scopus
  143. M. E. Rubio and F. Soto, “Distinct localization of P2X receptors at excitatory postsynaptic specializations,” Journal of Neuroscience, vol. 21, no. 2, pp. 641–653, 2001. View at Google Scholar · View at Scopus
  144. J. Mateo, M. García-Lecea, M. T. Miras-Portugal, and E. Castro, “Ca2+ signals mediated by P2X-type purinoceptors in cultured cerebellar Purkinje cells,” Journal of Neuroscience, vol. 18, no. 5, pp. 1704–1712, 1998. View at Google Scholar · View at Scopus
  145. S. Kirischuk, V. Matiash, A. Kulik, N. Voitenko, P. Kostyuk, and A. Verkhratsky, “Activation of P2-purino-,α1-adreno and H1-histamine receptors triggers cytoplasmic calcium signalling in cerebellar Purkinje neurons,” Neuroscience, vol. 73, no. 3, pp. 643–647, 1996. View at Publisher · View at Google Scholar · View at Scopus
  146. M. R. S. Carmo, A. P. Simões, A. A. Fonteles, C. M. Souza, R. A. Cunha, and G. M. Andrade, “ATP P2Y1 receptors control cognitive deficits and neurotoxicity but not glial modifications induced by brain ischemia in mice,” European Journal of Neuroscience, vol. 39, no. 4, pp. 614–622, 2014. View at Publisher · View at Google Scholar · View at Scopus
  147. Y. Chin, M. Kishi, M. Sekino et al., “Involvement of glial P2Y1 receptors in cognitive deficit after focal cerebral stroke in a rodent model,” Journal of Neuroinflammation, vol. 10, article 95, 2013. View at Publisher · View at Google Scholar · View at Scopus
  148. A. M. Choo, W. J. Miller, Y.-C. Chen et al., “Antagonism of purinergic signalling improves recovery from traumatic brain injury,” Brain, vol. 136, no. 1, pp. 65–80, 2013. View at Publisher · View at Google Scholar · View at Scopus
  149. J. Chen, Z. Tan, L. Zeng et al., “Heterosynaptic long-term depression mediated by ATP released from astrocytes,” Glia, vol. 61, no. 2, pp. 178–191, 2013. View at Publisher · View at Google Scholar · View at Scopus
  150. S. J. Guzman, H. Schmidt, H. Franke et al., “P2Y1 receptors inhibit long-term depression in the prefrontal cortex,” Neuropharmacology, vol. 59, no. 6, pp. 406–415, 2010. View at Publisher · View at Google Scholar · View at Scopus
  151. F. Pedata, I. Dettori, E. Coppi et al., “Purinergic signalling in brain ischemia,” Neuropharmacology, 2015. View at Publisher · View at Google Scholar
  152. R. J. Rodrigues, A. R. Tomé, and R. A. Cunha, “ATP as a multi-target danger signal in the brain,” Frontiers in Neuroscience, vol. 9, article 148, 2015. View at Publisher · View at Google Scholar
  153. H. Franke, U. Krügel, R. Schmidt, J. Grosche, A. Reichenbach, and P. Illes, “P2 receptor-types involved in astrogliosis in vivo,” British Journal of Pharmacology, vol. 134, no. 6, pp. 1180–1189, 2001. View at Publisher · View at Google Scholar · View at Scopus
  154. J.-J. Sun, Y. Liu, and Z.-R. Ye, “Effects of P2Y1 receptor on glial fibrillary acidic protein and glial cell line-derived neurotrophic factor production of astrocytes under ischemic condition and the related signaling pathways,” Neuroscience Bulletin, vol. 24, no. 4, pp. 231–243, 2008. View at Publisher · View at Google Scholar · View at Scopus
  155. A. Delekate, M. Füchtemeier, T. Schumacher, C. Ulbrich, M. Foddis, and G. C. Petzold, “Metabotropic P2Y1 receptor signalling mediates astrocytic hyperactivity in vivo in an Alzheimer’s disease mouse model,” Nature Communications, vol. 5, article 5422, 2014. View at Publisher · View at Google Scholar
  156. D. Moore, S. Iritani, J. Chambers, and P. Emson, “Immunohistochemical localization of the P2Y1 purinergic receptor in Alzheimer's disease,” NeuroReport, vol. 11, no. 17, pp. 3799–3803, 2000. View at Publisher · View at Google Scholar · View at Scopus
  157. L. Erb, C. Cao, D. Ajit, and G. A. Weisman, “P2Y receptors in Alzheimer's disease,” Biology of the Cell, vol. 107, no. 1, pp. 1–21, 2015. View at Publisher · View at Google Scholar · View at Scopus
  158. L. T. Woods, D. Ajit, J. M. Camden, L. Erb, and G. A. Weisman, “Purinergic receptors as potential therapeutic targets in Alzheimer's disease,” Neuropharmacology, 2015. View at Publisher · View at Google Scholar
  159. T. S. Peterson, J. M. Camden, Y. Wang et al., “P2Y2 nucleotide receptor-mediated responses in brain cells,” Molecular Neurobiology, vol. 41, no. 2-3, pp. 356–366, 2010. View at Publisher · View at Google Scholar · View at Scopus
  160. H. J. Kim, D. Ajit, T. S. Peterson et al., “Nucleotides released from Aβ1–42-treated microglial cells increase cell migration and Aβ1–42 uptake through P2Y2 receptor activation,” Journal of Neurochemistry, vol. 121, no. 2, pp. 228–238, 2012. View at Publisher · View at Google Scholar
  161. D. Ajit, L. T. Woods, J. M. Camden et al., “Loss of P2Y2 nucleotide receptors enhances early pathology in the TgCRND8 mouse model of Alzheimer's disease,” Molecular Neurobiology, vol. 49, no. 2, pp. 1031–1042, 2014. View at Publisher · View at Google Scholar · View at Scopus
  162. H.-Q. Li, C. Chen, Y. Dou et al., “P2Y4 receptor-mediated pinocytosis contributes to amyloid beta-induced self-uptake by microglia,” Molecular and Cellular Biology, vol. 33, no. 21, pp. 4282–4293, 2013. View at Publisher · View at Google Scholar · View at Scopus
  163. S. E. Haynes, G. Hollopeter, G. Yang et al., “The P2Y12 receptor regulates microglial activation by extracellular nucleotides,” Nature Neuroscience, vol. 9, no. 12, pp. 1512–1519, 2006. View at Publisher · View at Google Scholar · View at Scopus
  164. S. Espada, F. Ortega, E. Molina-Jijón et al., “The purinergic P2Y13 receptor activates the Nrf2/HO-1 axis and protects against oxidative stress-induced neuronal death,” Free Radical Biology and Medicine, vol. 49, no. 3, pp. 416–426, 2010. View at Publisher · View at Google Scholar · View at Scopus